nivolumab,varlilumab,ipilimumab
celldex,bms
['diciple', 'dial trial', 'congrat', 'nsclc', 'nivo', 'ipi+', 'sclc']
updated os with a 3-year follow-up of diciple phase 3 trial (ipi+nivo 1rst-line #nsclc): proof-of-concept of desescalation of #immunotherapy is confirmed! #asco23 congrats to and !
next step with dial trial: 
IFCT is a French cooperative thoracic intergroup sponsoring clinical research to improve survival and quality of life of patients with lung cancer.